Placebo-controlled studies in schizophrenia—ethical and scientific perspectives: an overview of conference proceedings
- 12 February 1999
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 35 (3) , 189-200
- https://doi.org/10.1016/s0920-9964(98)00124-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Are Medication-Free Periods Necessary for Phase 3 Trials of New Antipsychotic Drugs?Archives of General Psychiatry, 1998
- Quetiapine in Patients With SchizophreniaArchives of General Psychiatry, 1997
- The Call of the SirensArchives of General Psychiatry, 1997
- Medication-Free Research With Schizophrenic PatientsArchives of General Psychiatry, 1997
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- The Helsinki DeclarationJournal of Clinical Psychopharmacology, 1995
- The Continuing Unethical Use of Placebo ControlsNew England Journal of Medicine, 1994
- Neuroleptics and the Natural Course of SchizophreniaSchizophrenia Bulletin, 1991
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- Does short term placebo treatment of chronic schizophrenia produce long term harm?BMJ, 1986